Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib
Alfonso Quintás-Cardama, Hagop Kantarjian, Jianqin Shan, Elias Jabbour, Lynne V. Abruzzo, Srdan Verstovsek, Guillermo Garcia-Manero, Susan O'Brien, Jorge Cortes
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib'. Together they form a unique fingerprint.